Ankylosing Spondylitis Drug Market Report

Europe Ankylosing Spondylitis Drug Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jan 15, 2020
  • PAGES：159
  • REPORT CODE：GMM436675
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Ankylosing Spondylitis Drug market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.4% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Ankylosing Spondylitis Drug Market Segmentations:

    By Player:

    • Schering-Plough

    • Amgen

    • Mitsubishi Tanabe

    • Johnson & Johnson

    • Takeda

    • Abbott

    • Pfizer

    • Centocor

    • Wyeth

    • Eisai

    By Type:

    • Cimzia

    • Enbrel

    • Humira

    • Remicade

    • Simponi

    • Others

    By End-User:

    • Hospitals

    • Clinics

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Ankylosing Spondylitis Drug Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Ankylosing Spondylitis Drug Market Size and Growth Rate of Cimzia from 2014 to 2026

    • 1.3.2 Europe Ankylosing Spondylitis Drug Market Size and Growth Rate of Enbrel from 2014 to 2026

    • 1.3.3 Europe Ankylosing Spondylitis Drug Market Size and Growth Rate of Humira from 2014 to 2026

    • 1.3.4 Europe Ankylosing Spondylitis Drug Market Size and Growth Rate of Remicade from 2014 to 2026

    • 1.3.5 Europe Ankylosing Spondylitis Drug Market Size and Growth Rate of Simponi from 2014 to 2026

    • 1.3.6 Europe Ankylosing Spondylitis Drug Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Ankylosing Spondylitis Drug Market Size and Growth Rate of Hospitals from 2014 to 2026

    • 1.4.2 Europe Ankylosing Spondylitis Drug Market Size and Growth Rate of Clinics from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Ankylosing Spondylitis Drug Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Ankylosing Spondylitis Drug by Major Types

      • 3.4.1 Market Size and Growth Rate of Cimzia

      • 3.4.2 Market Size and Growth Rate of Enbrel

      • 3.4.3 Market Size and Growth Rate of Humira

      • 3.4.4 Market Size and Growth Rate of Remicade

      • 3.4.5 Market Size and Growth Rate of Simponi

      • 3.4.6 Market Size and Growth Rate of Others

    4 Segmentation of Ankylosing Spondylitis Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Ankylosing Spondylitis Drug by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Ankylosing Spondylitis Drug for Hospitals

      • 4.4.2 Market Size and Growth Rate of Ankylosing Spondylitis Drug for Clinics

    5 Market Analysis by Major Regions

    • 5.1 Europe Ankylosing Spondylitis Drug Production Analysis by Top Regions

    • 5.2 Europe Ankylosing Spondylitis Drug Consumption Analysis by Top Regions

    • 5.3 Europe Ankylosing Spondylitis Drug Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Ankylosing Spondylitis Drug Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Ankylosing Spondylitis Drug Production, Import, Consumption and Export Analysis

      • 5.3.3 France Ankylosing Spondylitis Drug Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Ankylosing Spondylitis Drug Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Ankylosing Spondylitis Drug Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Ankylosing Spondylitis Drug Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Ankylosing Spondylitis Drug Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Ankylosing Spondylitis Drug Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Ankylosing Spondylitis Drug Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Ankylosing Spondylitis Drug Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Ankylosing Spondylitis Drug Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Ankylosing Spondylitis Drug Production, Import, Consumption and Export Analysis

    6 Product Circulation of Ankylosing Spondylitis Drug Market among Top Countries

    • 6.1 Top 5 Export Countries in Ankylosing Spondylitis Drug Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Ankylosing Spondylitis Drug Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Ankylosing Spondylitis Drug Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Ankylosing Spondylitis Drug Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Ankylosing Spondylitis Drug Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Ankylosing Spondylitis Drug Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Ankylosing Spondylitis Drug Landscape Analysis

    • 7.1 Germany Ankylosing Spondylitis Drug Landscape Analysis by Major Types

    • 7.2 Germany Ankylosing Spondylitis Drug Landscape Analysis by Major End-Users

    8. UK Ankylosing Spondylitis Drug Landscape Analysis

    • 8.1 UK Ankylosing Spondylitis Drug Landscape Analysis by Major Types

    • 8.2 UK Ankylosing Spondylitis Drug Landscape Analysis by Major End-Users

    9. France Ankylosing Spondylitis Drug Landscape Analysis

    • 9.1 France Ankylosing Spondylitis Drug Landscape Analysis by Major Types

    • 9.2 France Ankylosing Spondylitis Drug Landscape Analysis by Major End-Users

    10. Italy Ankylosing Spondylitis Drug Landscape Analysis

    • 10.1 Italy Ankylosing Spondylitis Drug Landscape Analysis by Major Types

    • 10.2 Italy Ankylosing Spondylitis Drug Landscape Analysis by Major End-Users

    11. Spain Ankylosing Spondylitis Drug Landscape Analysis

    • 11.1 Spain Ankylosing Spondylitis Drug Landscape Analysis by Major Types

    • 11.2 Spain Ankylosing Spondylitis Drug Landscape Analysis by Major End-Users

    12. Poland Ankylosing Spondylitis Drug Landscape Analysis

    • 12.1 Poland Ankylosing Spondylitis Drug Landscape Analysis by Major Types

    • 12.2 Poland Ankylosing Spondylitis Drug Landscape Analysis by Major End-Users

    13. Russia Ankylosing Spondylitis Drug Landscape Analysis

    • 13.1 Russia Ankylosing Spondylitis Drug Landscape Analysis by Major Types

    • 13.2 Russia Ankylosing Spondylitis Drug Landscape Analysis by Major End-Users

    14. Switzerland Ankylosing Spondylitis Drug Landscape Analysis

    • 14.1 Switzerland Ankylosing Spondylitis Drug Landscape Analysis by Major Types

    • 14.2 Switzerland Ankylosing Spondylitis Drug Landscape Analysis by Major End-Users

    15. Turkey Ankylosing Spondylitis Drug Landscape Analysis

    • 15.1 Turkey Ankylosing Spondylitis Drug Landscape Analysis by Major Types

    • 15.2 Turkey Ankylosing Spondylitis Drug Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Ankylosing Spondylitis Drug Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Ankylosing Spondylitis Drug Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Ankylosing Spondylitis Drug Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Ankylosing Spondylitis Drug Landscape Analysis by Top Countries

      • 16.3.1 Denmark Ankylosing Spondylitis Drug Market Volume and Growth Rate

      • 16.3.2 Finland Ankylosing Spondylitis Drug Market Volume and Growth Rate

      • 16.3.3 Norway Ankylosing Spondylitis Drug Market Volume and Growth Rate

      • 16.3.4 Sweden Ankylosing Spondylitis Drug Market Volume and Growth Rate

      • 16.3.6 Iceland Ankylosing Spondylitis Drug Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Ankylosing Spondylitis Drug Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Ankylosing Spondylitis Drug Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Ankylosing Spondylitis Drug Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Ankylosing Spondylitis Drug Landscape Analysis by Top Countries

      • 17.3.1 Belgium Ankylosing Spondylitis Drug Market Volume and Growth Rate

      • 17.3.2 Netherlands Ankylosing Spondylitis Drug Market Volume and Growth Rate

      • 17.3.3 Luxembourg Ankylosing Spondylitis Drug Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Ankylosing Spondylitis Drug Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Ankylosing Spondylitis Drug Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Ankylosing Spondylitis Drug Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Ankylosing Spondylitis Drug Landscape Analysis by Top Countries

      • 18.3.1 Estonia Ankylosing Spondylitis Drug Market Volume and Growth Rate

      • 18.3.2 Latvia Ankylosing Spondylitis Drug Market Volume and Growth Rate

      • 18.3.3 Lithuania Ankylosing Spondylitis Drug Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Schering-Plough

      • 19.1.1 Schering-Plough Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Amgen

      • 19.2.1 Amgen Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Mitsubishi Tanabe

      • 19.3.1 Mitsubishi Tanabe Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Johnson & Johnson

      • 19.4.1 Johnson & Johnson Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Takeda

      • 19.5.1 Takeda Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Abbott

      • 19.6.1 Abbott Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Pfizer

      • 19.7.1 Pfizer Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Centocor

      • 19.8.1 Centocor Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Wyeth

      • 19.9.1 Wyeth Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Eisai

      • 19.10.1 Eisai Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    The List of Tables and Figures (Totals 105 Figures and 140 Tables)

    • Figure Product Picture

    • Figure Europe Ankylosing Spondylitis Drug Market Size and Growth Rate of Cimzia from 2014 to 2026

    • Figure Europe Ankylosing Spondylitis Drug Market Size and Growth Rate of Enbrel from 2014 to 2026

    • Figure Europe Ankylosing Spondylitis Drug Market Size and Growth Rate of Humira from 2014 to 2026

    • Figure Europe Ankylosing Spondylitis Drug Market Size and Growth Rate of Remicade from 2014 to 2026

    • Figure Europe Ankylosing Spondylitis Drug Market Size and Growth Rate of Simponi from 2014 to 2026

    • Figure Europe Ankylosing Spondylitis Drug Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Europe Ankylosing Spondylitis Drug Market Size and Growth Rate of Hospitals from 2014 to 2026

    • Figure Europe Ankylosing Spondylitis Drug Market Size and Growth Rate of Clinics from 2014 to 2026

    • Figure Germany Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

    • Figure UK Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

    • Figure France Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Ankylosing Spondylitis Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Ankylosing Spondylitis Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Ankylosing Spondylitis Drug

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Ankylosing Spondylitis Drug by Different Types from 2014 to 2026

    • Table Consumption Share of Ankylosing Spondylitis Drug by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Cimzia

    • Figure Market Size and Growth Rate of Enbrel

    • Figure Market Size and Growth Rate of Humira

    • Figure Market Size and Growth Rate of Remicade

    • Figure Market Size and Growth Rate of Simponi

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Ankylosing Spondylitis Drug by Different End-Users from 2014 to 2026

    • Table Consumption Share of Ankylosing Spondylitis Drug by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Clinics

    • Table Europe Ankylosing Spondylitis Drug Production by Major Regions

    • Table Europe Ankylosing Spondylitis Drug Production Share by Major Regions

    • Figure Europe Ankylosing Spondylitis Drug Production Share by Major Countries and Regions in 2014

    • Table Europe Ankylosing Spondylitis Drug Consumption by Major Regions

    • Table Europe Ankylosing Spondylitis Drug Consumption Share by Major Regions

    • Table Germany Ankylosing Spondylitis Drug Production, Import, Consumption and Export Analysis

    • Table UK Ankylosing Spondylitis Drug Production, Import, Consumption and Export Analysis

    • Table France Ankylosing Spondylitis Drug Production, Import, Consumption and Export Analysis

    • Table Italy Ankylosing Spondylitis Drug Production, Import, Consumption and Export Analysis

    • Table Spain Ankylosing Spondylitis Drug Production, Import, Consumption and Export Analysis

    • Table Poland Ankylosing Spondylitis Drug Production, Import, Consumption and Export Analysis

    • Table Russia Ankylosing Spondylitis Drug Production, Import, Consumption and Export Analysis

    • Table Switzerland Ankylosing Spondylitis Drug Production, Import, Consumption and Export Analysis

    • Table Turkey Ankylosing Spondylitis Drug Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Ankylosing Spondylitis Drug Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Ankylosing Spondylitis Drug Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Ankylosing Spondylitis Drug Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Ankylosing Spondylitis Drug Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Ankylosing Spondylitis Drug Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Ankylosing Spondylitis Drug Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Ankylosing Spondylitis Drug Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Ankylosing Spondylitis Drug Consumption by Types from 2014 to 2026

    • Table Germany Ankylosing Spondylitis Drug Consumption Share by Types from 2014 to 2026

    • Table Germany Ankylosing Spondylitis Drug Consumption by End-Users from 2014 to 2026

    • Table Germany Ankylosing Spondylitis Drug Consumption Share by End-Users from 2014 to 2026

    • Table UK Ankylosing Spondylitis Drug Consumption by Types from 2014 to 2026

    • Table UK Ankylosing Spondylitis Drug Consumption Share by Types from 2014 to 2026

    • Table UK Ankylosing Spondylitis Drug Consumption by End-Users from 2014 to 2026

    • Table UK Ankylosing Spondylitis Drug Consumption Share by End-Users from 2014 to 2026

    • Table France Ankylosing Spondylitis Drug Consumption by Types from 2014 to 2026

    • Table France Ankylosing Spondylitis Drug Consumption Share by Types from 2014 to 2026

    • Table France Ankylosing Spondylitis Drug Consumption by End-Users from 2014 to 2026

    • Table France Ankylosing Spondylitis Drug Consumption Share by End-Users from 2014 to 2026

    • Table Italy Ankylosing Spondylitis Drug Consumption by Types from 2014 to 2026

    • Table Italy Ankylosing Spondylitis Drug Consumption Share by Types from 2014 to 2026

    • Table Italy Ankylosing Spondylitis Drug Consumption by End-Users from 2014 to 2026

    • Table Italy Ankylosing Spondylitis Drug Consumption Share by End-Users from 2014 to 2026

    • Table Spain Ankylosing Spondylitis Drug Consumption by Types from 2014 to 2026

    • Table Spain Ankylosing Spondylitis Drug Consumption Share by Types from 2014 to 2026

    • Table Spain Ankylosing Spondylitis Drug Consumption by End-Users from 2014 to 2026

    • Table Spain Ankylosing Spondylitis Drug Consumption Share by End-Users from 2014 to 2026

    • Table Poland Ankylosing Spondylitis Drug Consumption by Types from 2014 to 2026

    • Table Poland Ankylosing Spondylitis Drug Consumption Share by Types from 2014 to 2026

    • Table Poland Ankylosing Spondylitis Drug Consumption by End-Users from 2014 to 2026

    • Table Poland Ankylosing Spondylitis Drug Consumption Share by End-Users from 2014 to 2026

    • Table Russia Ankylosing Spondylitis Drug Consumption by Types from 2014 to 2026

    • Table Russia Ankylosing Spondylitis Drug Consumption Share by Types from 2014 to 2026

    • Table Russia Ankylosing Spondylitis Drug Consumption by End-Users from 2014 to 2026

    • Table Russia Ankylosing Spondylitis Drug Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Ankylosing Spondylitis Drug Consumption by Types from 2014 to 2026

    • Table Switzerland Ankylosing Spondylitis Drug Consumption Share by Types from 2014 to 2026

    • Table Switzerland Ankylosing Spondylitis Drug Consumption by End-Users from 2014 to 2026

    • Table Switzerland Ankylosing Spondylitis Drug Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Ankylosing Spondylitis Drug Consumption by Types from 2014 to 2026

    • Table Turkey Ankylosing Spondylitis Drug Consumption Share by Types from 2014 to 2026

    • Table Turkey Ankylosing Spondylitis Drug Consumption by End-Users from 2014 to 2026

    • Table Turkey Ankylosing Spondylitis Drug Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Ankylosing Spondylitis Drug Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Ankylosing Spondylitis Drug Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Ankylosing Spondylitis Drug Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Ankylosing Spondylitis Drug Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Ankylosing Spondylitis Drug Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Ankylosing Spondylitis Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Ankylosing Spondylitis Drug Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Ankylosing Spondylitis Drug Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Ankylosing Spondylitis Drug Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Ankylosing Spondylitis Drug Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Ankylosing Spondylitis Drug Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Ankylosing Spondylitis Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Ankylosing Spondylitis Drug Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Ankylosing Spondylitis Drug Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Ankylosing Spondylitis Drug Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Ankylosing Spondylitis Drug Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Ankylosing Spondylitis Drug Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Ankylosing Spondylitis Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Schering-Plough

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Schering-Plough

    • Figure Sales and Growth Rate Analysis of Schering-Plough

    • Figure Revenue and Market Share Analysis of Schering-Plough

    • Table Product and Service Introduction of Schering-Plough

    • Table Company Profile and Development Status of Amgen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen

    • Figure Sales and Growth Rate Analysis of Amgen

    • Figure Revenue and Market Share Analysis of Amgen

    • Table Product and Service Introduction of Amgen

    • Table Company Profile and Development Status of Mitsubishi Tanabe

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mitsubishi Tanabe

    • Figure Sales and Growth Rate Analysis of Mitsubishi Tanabe

    • Figure Revenue and Market Share Analysis of Mitsubishi Tanabe

    • Table Product and Service Introduction of Mitsubishi Tanabe

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of Takeda

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda

    • Figure Sales and Growth Rate Analysis of Takeda

    • Figure Revenue and Market Share Analysis of Takeda

    • Table Product and Service Introduction of Takeda

    • Table Company Profile and Development Status of Abbott

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott

    • Figure Sales and Growth Rate Analysis of Abbott

    • Figure Revenue and Market Share Analysis of Abbott

    • Table Product and Service Introduction of Abbott

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Centocor

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Centocor

    • Figure Sales and Growth Rate Analysis of Centocor

    • Figure Revenue and Market Share Analysis of Centocor

    • Table Product and Service Introduction of Centocor

    • Table Company Profile and Development Status of Wyeth

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Wyeth

    • Figure Sales and Growth Rate Analysis of Wyeth

    • Figure Revenue and Market Share Analysis of Wyeth

    • Table Product and Service Introduction of Wyeth

    • Table Company Profile and Development Status of Eisai

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai

    • Figure Sales and Growth Rate Analysis of Eisai

    • Figure Revenue and Market Share Analysis of Eisai

    • Table Product and Service Introduction of Eisai

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US